Paul S. Jellinger
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 2%
- Lipoproteins and Cardiovascular Health
- Pancreatic function and diabetes
Papers in
-
- Diabetes Management and Research 19
- Diabetes Treatment and Management 16
- Diabetes, Cardiovascular Risks, and Lipoproteins 12
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 5
- Surgery 8
- Lipoproteins and Cardiovascular Health 7
- Co-authors
- Yehuda Handelsman (19 shared papers)George Grunberger (15 shared papers)Alan J. Garber (13 shared papers)Zachary T. Bloomgarden (12 shared papers)Daniel Einhorn (13 shared papers)Paul D. Rosenblit (12 shared papers)Jeffrey I. Mechanick (11 shared papers)Michael A. Bush (10 shared papers)
- Journals
- Endocrine Practice (22 papers)Journal of Diabetes (1 paper)Current Medical Research and Opinion (1 paper)Clinical Cardiology (1 paper)Journal of Clinical Hypertension (1 paper)
- Partner nations
- United StatesAustraliaCzechia
In The Last Decade
Paul S. Jellinger
37 papers receiving 5.2k citations
Paul S. Jellinger's Hit Papers
Peers
Comparison fields: 5 of 124
- Endocrinology, Diabetes and Metabolism 2.9k
- Surgery 1.2k
- Pharmacology 399
- Family Practice 39
- Cardiology and Cardiovascular Medicine 390
Countries citing papers authored by Paul S. Jellinger
This map shows the geographic impact of Paul S. Jellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul S. Jellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul S. Jellinger more than expected).
Fields of papers citing papers by Paul S. Jellinger
This network shows the impact of papers produced by Paul S. Jellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul S. Jellinger. The network helps show where Paul S. Jellinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul S. Jellinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease Hit paper breakdown → | 2017 | 788 |
| 2 | Statement by an American Association of Clinical Endocrinologists/ American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control Hit paper breakdown → | 2009 | 753 |
| 3 | Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary Hit paper breakdown → | 2020 | 422 |
| 4 | American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis Hit paper breakdown → | 2012 | 409 |
| 5 | Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary Hit paper breakdown → | 2018 | 378 |
| 6 | Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm – 2017 Executive Summary Hit paper breakdown → | 2017 | 331 |
| 7 | 2013 | 320 | |
| 8 | 2013 | 241 | |
| 9 | 2019 | 227 | |
| 10 | 2008 | 180 | |
| 11 | 2015 | 179 | |
| 12 | 2013 | 167 | |
| 13 | 2020 | 159 | |
| 14 | 2017 | 144 | |
| 15 | 2012 | 94 | |
| 16 | 2007 | 88 | |
| 17 | 2005 | 77 | |
| 18 | 2007 | 73 | |
| 19 | 2017 | 71 | |
| 20 | 2008 | 67 |
About Paul S. Jellinger
Paul S. Jellinger is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Pharmacology, Economics and Econometrics and Molecular Biology, having authored 38 papers that have together received 5.5k indexed citations. Recurring topics across this work include Diabetes Management and Research (19 papers), Diabetes Treatment and Management (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Lipoproteins and Cardiovascular Health (7 papers), Pharmacology and Obesity Treatment (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.9k citations), Surgery (1.2k citations), Pharmacology (399 citations), Family Practice (39 citations) and Cardiology and Cardiovascular Medicine (390 citations). Paul S. Jellinger has collaborated with scholars based in United States, Australia and Czechia. Frequent co-authors include Yehuda Handelsman, George Grunberger, Alan J. Garber, Zachary T. Bloomgarden, Daniel Einhorn, Paul D. Rosenblit, Jeffrey I. Mechanick, Michael A. Bush, Lawrence Blonde and Guillermo E. Umpierrez. Their work appears in journals such as Endocrine Practice, Journal of Diabetes, Current Medical Research and Opinion, Clinical Cardiology and Journal of Clinical Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.